tetano
Editor, Senior Moderator
Pediatr Pulmonol
. 2021 Jan 6.
doi: 10.1002/ppul.25255. Online ahead of print.
Lung ultrasound in the diagnosis and monitoring of 30 children with Coronavirus Disease 2019
Musolino Anna Maria[SUP] 1 [/SUP], Supino Maria Chiara[SUP] 1 [/SUP], Danilo Buonsenso[SUP] 2 [/SUP], Raffaele Edo Papa[SUP] 3 [/SUP], Sara Chiurchi?[SUP] 4 [/SUP], Andrea Magistrelli[SUP] 5 [/SUP], Maria Antonietta Barbieri[SUP] 6 [/SUP], Massimiliano Raponi[SUP] 7 [/SUP], Patrizia D'Argenio[SUP] 4 [/SUP], Alberto Villani[SUP] 8 [/SUP], Paolo Tom?[SUP] 5 [/SUP], LUS Covid group
Affiliations
Abstract
Background: The Coronavirus Disease 2019 (COVID-19) has caused a new global pandemic and is responsible for millions of infections and thousands of deaths in the world. The lung ultrasound is a non-invasive and easily repeatable tool and can be carried out by the pediatrician at the bedside of children with a consequent reduction in the risk of transmission of the virus.
Objective: We hypothesized that ultrasound findings in these patients would (1) be associated with their disease severity and (2) change over time in alignment with clinical outcome.
Methods: The study was made in the emergency department in a tertiary level pediatric hospital. All patients with swab-confirmed COVID-19 infection were subjected to a lung ultrasound within 6 hours from admission and after 96 hours.
Results: Among a total of 30 children, 18 (60%) were males, 4 reported exertional dyspnea and only 1 chest pain. The mean oxygen saturation was 98.8 ? 1.0 % in ambient air in emergency department and no patient needed oxygen therapy during hospitalization. Children with moderate disease presented more B line (p= 0.03). After 96 hours we had observed ultrasound abnormality only in 20% of the children. We found a statistically significant reduction in pleural irregularities (30% vs 16.7; p= 0.001) and in B lines (50% vs 20%; p= 0.008).
Conclusions: The lung ultrasound is a useful, feasible and safe tool for the clinician to complement the clinical evaluation and to monitor the evolution of lung disease in children with COVID-19. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; Children; Coronavirus disease 2019; Lung Ultrasound; SARS-CoV2.
. 2021 Jan 6.
doi: 10.1002/ppul.25255. Online ahead of print.
Lung ultrasound in the diagnosis and monitoring of 30 children with Coronavirus Disease 2019
Musolino Anna Maria[SUP] 1 [/SUP], Supino Maria Chiara[SUP] 1 [/SUP], Danilo Buonsenso[SUP] 2 [/SUP], Raffaele Edo Papa[SUP] 3 [/SUP], Sara Chiurchi?[SUP] 4 [/SUP], Andrea Magistrelli[SUP] 5 [/SUP], Maria Antonietta Barbieri[SUP] 6 [/SUP], Massimiliano Raponi[SUP] 7 [/SUP], Patrizia D'Argenio[SUP] 4 [/SUP], Alberto Villani[SUP] 8 [/SUP], Paolo Tom?[SUP] 5 [/SUP], LUS Covid group
Affiliations
- PMID: 33404197
- DOI: 10.1002/ppul.25255
Abstract
Background: The Coronavirus Disease 2019 (COVID-19) has caused a new global pandemic and is responsible for millions of infections and thousands of deaths in the world. The lung ultrasound is a non-invasive and easily repeatable tool and can be carried out by the pediatrician at the bedside of children with a consequent reduction in the risk of transmission of the virus.
Objective: We hypothesized that ultrasound findings in these patients would (1) be associated with their disease severity and (2) change over time in alignment with clinical outcome.
Methods: The study was made in the emergency department in a tertiary level pediatric hospital. All patients with swab-confirmed COVID-19 infection were subjected to a lung ultrasound within 6 hours from admission and after 96 hours.
Results: Among a total of 30 children, 18 (60%) were males, 4 reported exertional dyspnea and only 1 chest pain. The mean oxygen saturation was 98.8 ? 1.0 % in ambient air in emergency department and no patient needed oxygen therapy during hospitalization. Children with moderate disease presented more B line (p= 0.03). After 96 hours we had observed ultrasound abnormality only in 20% of the children. We found a statistically significant reduction in pleural irregularities (30% vs 16.7; p= 0.001) and in B lines (50% vs 20%; p= 0.008).
Conclusions: The lung ultrasound is a useful, feasible and safe tool for the clinician to complement the clinical evaluation and to monitor the evolution of lung disease in children with COVID-19. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; Children; Coronavirus disease 2019; Lung Ultrasound; SARS-CoV2.